Angiogenic Factors and the Risk of Adverse Outcomes

Post a reply


In an effort to prevent automatic submissions, we require that you type the text displayed into the field underneath.
Smilies
:D :) ;) :( :o :shock: :? 8-) :lol: :x :P :oops: :cry: :evil: :twisted: :roll: :!: :?: :idea: :arrow: :| :mrgreen: :geek: :ugeek:

BBCode is ON
[img] is ON
[flash] is OFF
[url] is ON
Smilies are ON

Topic review
   

If you wish to attach one or more files enter the details below.

Expand view Topic review: Angiogenic Factors and the Risk of Adverse Outcomes

Angiogenic Factors and the Risk of Adverse Outcomes

Post by caryn » Tue Jan 24, 2012 03:15 pm

In women with suspected preeclampsia presenting at <34 weeks, circulating sFlt1/PlGF ratio predicts adverse outcomes occurring within two weeks. The accuracy of this test is substantially better than current approaches and may be useful in risk stratification and management. Additional studies are warranted to validate these findings.

http://www.ncbi.nlm.nih.gov/pubmed/22261192

So for women tested before 34 weeks, measuring how much soluble FLT and how much placental growth factor were in the maternal bloodstream, and expressing them as a ratio had very statistically significant predictive value for stuff going explosively wrong. But of course, this needs to be confirmed by an independent research team or two (to rule out confirmation bias - finding what you want to find!) and developed into a commercial test if it's confirmed.

Top